Trial Profile
Efficacy and tolerability of Perampanel in children under 12 years of age with refractory epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Nov 2017
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- 13 Nov 2017 New trial record